Anti-HIV-1 antibody-dependent cellular cytotoxicity

Is there more to antibodies than neutralization?

Wen Shi Lee, Stephen J. Kent

Research output: Contribution to journalReview ArticleOtherpeer-review

5 Citations (Scopus)

Abstract

Purpose of review An increasing body of evidence suggests that nonneutralizing Fc effector functions including antibody-dependent cellular cytotoxicity (ADCC) contribute to protection against HIV-1 acquisition. We discuss recent advances in anti-HIV-1 ADCC research with a particular focus on ADCC mediated by Env-specific antibodies in vitro and in vivo, the curative potential of HIV-1-specific ADCC antibodies and the mechanisms of HIV-1 resistance to ADCC. Recent findings ADCC activities of broadly neutralizing and nonneutralizing monoclonal antibody panels were recently characterized in vitro against several lab-adapted and primary isolates of HIV-1. ADCC activity of these monoclonal antibodies generally correlated with binding to infected cells and were greater against the lab-adapted strains compared with primary HIV-1 isolates. Several recent studies in mouse and macaque models of HIV-1 infection suggest Fc-mediated effector functions contribute to the protective efficacy of broadly neutralizing antibodies and exert immune pressure on HIV-1 in vivo. Summary An increasing body of evidence suggests that ADCC-mediating antibodies, particularly when combined with neutralizing functions, can facilitate prevention and control of HIV-1. The precise mechanisms of partial protection conferred by nonneutralizing antibodies in vivo remain unclear and will need to be fully investigated in order to realize their full potential for HIV-1 vaccines.

Original languageEnglish
Pages (from-to)160-166
Number of pages7
JournalCurrent Opinion in HIV and AIDS
Volume13
Issue number2
DOIs
Publication statusPublished - 1 Mar 2018

Keywords

  • antibody-dependent cellular cytotoxicity
  • broadly neutralizing antibody
  • Fc-mediated effector functions
  • nonneutralizing

Cite this

@article{54072e76e94b4ff2939addefcb0f5365,
title = "Anti-HIV-1 antibody-dependent cellular cytotoxicity: Is there more to antibodies than neutralization?",
abstract = "Purpose of review An increasing body of evidence suggests that nonneutralizing Fc effector functions including antibody-dependent cellular cytotoxicity (ADCC) contribute to protection against HIV-1 acquisition. We discuss recent advances in anti-HIV-1 ADCC research with a particular focus on ADCC mediated by Env-specific antibodies in vitro and in vivo, the curative potential of HIV-1-specific ADCC antibodies and the mechanisms of HIV-1 resistance to ADCC. Recent findings ADCC activities of broadly neutralizing and nonneutralizing monoclonal antibody panels were recently characterized in vitro against several lab-adapted and primary isolates of HIV-1. ADCC activity of these monoclonal antibodies generally correlated with binding to infected cells and were greater against the lab-adapted strains compared with primary HIV-1 isolates. Several recent studies in mouse and macaque models of HIV-1 infection suggest Fc-mediated effector functions contribute to the protective efficacy of broadly neutralizing antibodies and exert immune pressure on HIV-1 in vivo. Summary An increasing body of evidence suggests that ADCC-mediating antibodies, particularly when combined with neutralizing functions, can facilitate prevention and control of HIV-1. The precise mechanisms of partial protection conferred by nonneutralizing antibodies in vivo remain unclear and will need to be fully investigated in order to realize their full potential for HIV-1 vaccines.",
keywords = "antibody-dependent cellular cytotoxicity, broadly neutralizing antibody, Fc-mediated effector functions, nonneutralizing",
author = "Lee, {Wen Shi} and Kent, {Stephen J.}",
year = "2018",
month = "3",
day = "1",
doi = "10.1097/COH.0000000000000439",
language = "English",
volume = "13",
pages = "160--166",
journal = "Current Opinion in HIV and AIDS",
issn = "1746-630X",
publisher = "Lippincott Williams & Wilkins",
number = "2",

}

Anti-HIV-1 antibody-dependent cellular cytotoxicity : Is there more to antibodies than neutralization? / Lee, Wen Shi; Kent, Stephen J.

In: Current Opinion in HIV and AIDS, Vol. 13, No. 2, 01.03.2018, p. 160-166.

Research output: Contribution to journalReview ArticleOtherpeer-review

TY - JOUR

T1 - Anti-HIV-1 antibody-dependent cellular cytotoxicity

T2 - Is there more to antibodies than neutralization?

AU - Lee, Wen Shi

AU - Kent, Stephen J.

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Purpose of review An increasing body of evidence suggests that nonneutralizing Fc effector functions including antibody-dependent cellular cytotoxicity (ADCC) contribute to protection against HIV-1 acquisition. We discuss recent advances in anti-HIV-1 ADCC research with a particular focus on ADCC mediated by Env-specific antibodies in vitro and in vivo, the curative potential of HIV-1-specific ADCC antibodies and the mechanisms of HIV-1 resistance to ADCC. Recent findings ADCC activities of broadly neutralizing and nonneutralizing monoclonal antibody panels were recently characterized in vitro against several lab-adapted and primary isolates of HIV-1. ADCC activity of these monoclonal antibodies generally correlated with binding to infected cells and were greater against the lab-adapted strains compared with primary HIV-1 isolates. Several recent studies in mouse and macaque models of HIV-1 infection suggest Fc-mediated effector functions contribute to the protective efficacy of broadly neutralizing antibodies and exert immune pressure on HIV-1 in vivo. Summary An increasing body of evidence suggests that ADCC-mediating antibodies, particularly when combined with neutralizing functions, can facilitate prevention and control of HIV-1. The precise mechanisms of partial protection conferred by nonneutralizing antibodies in vivo remain unclear and will need to be fully investigated in order to realize their full potential for HIV-1 vaccines.

AB - Purpose of review An increasing body of evidence suggests that nonneutralizing Fc effector functions including antibody-dependent cellular cytotoxicity (ADCC) contribute to protection against HIV-1 acquisition. We discuss recent advances in anti-HIV-1 ADCC research with a particular focus on ADCC mediated by Env-specific antibodies in vitro and in vivo, the curative potential of HIV-1-specific ADCC antibodies and the mechanisms of HIV-1 resistance to ADCC. Recent findings ADCC activities of broadly neutralizing and nonneutralizing monoclonal antibody panels were recently characterized in vitro against several lab-adapted and primary isolates of HIV-1. ADCC activity of these monoclonal antibodies generally correlated with binding to infected cells and were greater against the lab-adapted strains compared with primary HIV-1 isolates. Several recent studies in mouse and macaque models of HIV-1 infection suggest Fc-mediated effector functions contribute to the protective efficacy of broadly neutralizing antibodies and exert immune pressure on HIV-1 in vivo. Summary An increasing body of evidence suggests that ADCC-mediating antibodies, particularly when combined with neutralizing functions, can facilitate prevention and control of HIV-1. The precise mechanisms of partial protection conferred by nonneutralizing antibodies in vivo remain unclear and will need to be fully investigated in order to realize their full potential for HIV-1 vaccines.

KW - antibody-dependent cellular cytotoxicity

KW - broadly neutralizing antibody

KW - Fc-mediated effector functions

KW - nonneutralizing

UR - http://www.scopus.com/inward/record.url?scp=85042455965&partnerID=8YFLogxK

U2 - 10.1097/COH.0000000000000439

DO - 10.1097/COH.0000000000000439

M3 - Review Article

VL - 13

SP - 160

EP - 166

JO - Current Opinion in HIV and AIDS

JF - Current Opinion in HIV and AIDS

SN - 1746-630X

IS - 2

ER -